<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-05T04:06:36Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/19821" metadataPrefix="qdc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/19821</identifier><datestamp>2026-02-03T11:00:56Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37953</setSpec></header><metadata><qdc:qualifieddc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>A comparative study of the antiangiogenic activity of hydroxytyrosyl alkyl ethers</dc:title>
   <dc:creator>Marrero Capitán, Ana Dácil</dc:creator>
   <dc:creator>Castilla, Laura</dc:creator>
   <dc:creator>Espartero Sánchez, José Luis</dc:creator>
   <dc:creator>Madrona, Andrés</dc:creator>
   <dc:creator>Rodríguez-Quesada, Ana María</dc:creator>
   <dc:creator>Medina-Torres, Miguel Ángel</dc:creator>
   <dc:creator>Martínez-Póveda, Beatriz Amparo</dc:creator>
   <dc:subject>Neovascularización</dc:subject>
   <dc:subject>Aceite de oliva</dc:subject>
   <dcterms:abstract>The phenolic compound hydroxytyrosol and its derivatives are responsible for some of the health benefits of the&#xd;
intake of virgin olive oil, having shown antiangiogenic properties. In this study, we explored the antiangiogenic&#xd;
potential of six synthetic hydroxytyrosyl alkyl ethers (HT C1, C2, C4, C6, C8 and C12). Our results showed that&#xd;
all compounds affected endothelial cell viability in vitro at low micromolar doses. In addition, compounds HT C1,&#xd;
C2, C4 and C6 inhibited endothelial cell migration and formation of tubular-like structures. In these assays,&#xd;
hydroxytyrosyl hexyl ether (HT C6) exhibited the most potent inhibitory activity in vitro, activating as well&#xd;
apoptosis in endothelial cells. Furthermore, the antiangiogenic activity of HT C6 was confirmed in vivo in the&#xd;
chick chorioallantoic membrane assay. Hence, we present hydroxytyrosol synthetic derivative HT C6 as a new&#xd;
antiangiogenic compound and as a good candidate for an antiangiogenic drug in the treatment of angiogenesisdependent&#xd;
diseases.</dcterms:abstract>
   <dcterms:dateAccepted>2020-09-22T10:10:29Z</dcterms:dateAccepted>
   <dcterms:available>2020-09-22T10:10:29Z</dcterms:available>
   <dcterms:created>2020-09-22T10:10:29Z</dcterms:created>
   <dcterms:issued>2020-09-22</dcterms:issued>
   <dc:type>journal article</dc:type>
   <dc:identifier>https://hdl.handle.net/10630/19821</dc:identifier>
   <dc:identifier>10.1016/j.foodchem.2020.127476</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
</qdc:qualifieddc>
</metadata></record></GetRecord></OAI-PMH>